[Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
作者信息
Rabadeau Dumas J L, Rondot P, Cardon P
出版信息
Therapie. 1977 Mar-Apr;32(2):161-72.
PMID:898124
Abstract
摘要
相似文献
1
2
[Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].[脱羧酶抑制剂与左旋多巴联合用于帕金森病的治疗]
Rev Prat. 1974 Mar 11;24(15):1211-2, 1215-6, 1219.
3
[CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].[CB 154治疗帕金森病。与左旋多巴和脱羧酶抑制剂联合使用的结果]
Acta Neurol (Napoli). 1976 Jul-Aug;31(4):479-48.
4
[Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].帕金森病患者在左旋多巴、金刚烷胺及左旋多巴+IDC治疗期间的心理变化（作者译）
Riv Patol Nerv Ment. 1974 Oct;95(5):676-84.
5
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].左旋多巴加脱羧酶抑制剂（卡比多巴、苄丝肼）联合治疗帕金森病（作者译）
Wien Klin Wochenschr. 1979 May 11;91(10):332-7.
6
7
8
[Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].左旋多巴与多巴脱羧酶抑制剂治疗帕金森病
Neurol Neurocir Psiquiatr. 1976;17(4):293-300.
9
Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.左旋多巴和脱羧酶抑制剂治疗老年帕金森病患者的患者获益情况。
Pharmatherapeutica. 1985;4(2):132-40.
Zotero 插件